{
  "case_id": "case_0009",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 37.07,
    "sex": "Male",
    "genderIdentity": "Transgender Female",
    "ancestry": "South Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve (cranial nerve II).",
      "structured_data": {
        "gt_lesions_english": [
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\n- Agree with also considering: Compressive Optic Neuropathy, Leber's Hereditary Optic Neuropathy, MOG Antibody-Associated Disease, Neuromyelitis Optica Spectrum Disorder (AQP4+), Neurosarcoidosis, Neurosyphilis, Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) and Toxic-Nutritional Optic Neuropathy.\n\nThis suggested differential is less likely to explain the full clinical picture than those above:\n- Tuberculous optic neuropathy",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple sclerosis\u2013associated optic neuritis",
          "MOG-antibody\u2013associated optic neuritis",
          "Aquaporin-4 neuromyelitis optica spectrum disorder",
          "Non-arteritic anterior ischemic optic neuropathy",
          "Compressive optic neuropathy (optic nerve sheath meningioma or orbital mass)",
          "Sarcoid optic neuritis",
          "Syphilitic optic neuritis",
          "Lyme neuroborreliosis\u2013related optic neuropathy",
          "Tuberculous optic neuropathy",
          "Toxic/nutritional optic neuropathy"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "Neurosarcoidosis",
          "Leber_Hereditary_Optic_Neuropathy",
          "Ischemic_Optic_Neuropathy_NAION",
          "Syphilis",
          "AQP4_NMOSD",
          "MS",
          "MOGAD",
          "Compressive_Optic_Neuropathy",
          "Toxic_Nutritional_Optic_Neuropathy"
        ],
        "missing_lesion_dx_keys": [],
        "additional_diagnoses": [
          "Tuberculous optic neuropathy"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_inappropriate_count": 1,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: serum AQP4 Ab, ESR and CRP, serum MOG Ab, serum ACE, syphilis, vitamin B12 level.\n- Could also consider: mitochondrial DNA testing for LHON mutations.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and orbits with gadolinium and fat-suppressed sequences",
          "MRI of cervical and thoracic spine with gadolinium",
          "Lumbar puncture with CSF cell count, protein, glucose, oligoclonal bands, Gram stain and culture",
          "Automated perimetry (Humphrey visual field)",
          "Optical coherence tomography (RNFL/GCL analysis)",
          "Visual evoked potentials",
          "AQP4-IgG (cell-based assay)",
          "MOG-IgG (cell-based assay)",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "Erythrocyte sedimentation rate",
          "C-reactive protein",
          "Blood glucose",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Anti-dsDNA antibody",
          "Serum ACE level",
          "Serum calcium",
          "Vitamin B12",
          "Thyroid-stimulating hormone",
          "HIV antigen/antibody test",
          "Syphilis serology (treponemal and non-treponemal)",
          "Lyme serology",
          "Quantiferon-TB Gold or T-Spot",
          "High-resolution CT chest (if sarcoidosis or TB suspected)"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "AQP4_Antibodies",
          "ESR_CRP",
          "MOG_Antibodies",
          "Mitochondrial_DNA_Testing",
          "Serum_ACE",
          "Syphilis_Serology",
          "Vitamin_B12"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "Vitamin_B12",
          "ESR_CRP",
          "Serum_ACE"
        ],
        "missing_inv_keys_ddx": [
          "Mitochondrial_DNA_Testing"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 2,
        "primary_tests_found_count": 2,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 7,
        "ddx_tests_found_count": 6,
        "ddx_tests_coverage_percentage": 0.8571428571428571
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: Airspace disease with air bronchograms right upper lobe.).\n\n- No indication this isn't an exacerbation of an old deficit/pseudorelapse.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: Airspace disease with air bronchograms right upper lobe.).",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute unilateral optic neuritis within treatment window",
              "Speeds visual recovery",
              "Standard first-line therapy for inflammatory optic neuritis"
            ]
          },
          {
            "treatment": "Oral prednisolone taper (e.g., 60 mg reducing over 11\u201314 days) after IV course",
            "timing": "Start Now",
            "reasons": [
              "Reduces early relapse risk after IV steroids",
              "Bridges steroid withdrawal following pulse therapy"
            ]
          },
          {
            "treatment": "Proton pump inhibitor and glucose/BP monitoring during steroids",
            "timing": "Start Now",
            "reasons": [
              "Mitigate gastrointestinal and metabolic adverse effects of high-dose steroids"
            ]
          },
          {
            "treatment": "Plasma exchange (5\u20137 exchanges)",
            "timing": "Delay",
            "reasons": [
              "Reserve for steroid-refractory or severe vision loss",
              "Initiate if no improvement within 3\u20135 days post-steroids or AQP4-positive severe attack"
            ]
          },
          {
            "treatment": "Multiple sclerosis disease-modifying therapy",
            "timing": "Delay",
            "reasons": [
              "Start only if MRI/CSF support MS diagnosis or high-risk clinically isolated syndrome",
              "Choice depends on lesion burden and patient factors"
            ]
          },
          {
            "treatment": "Rituximab or other NMOSD-directed immunotherapy",
            "timing": "Delay",
            "reasons": [
              "Indicated if AQP4-IgG positive or high clinical suspicion",
              "Requires serologic confirmation and specialist planning"
            ]
          },
          {
            "treatment": "Targeted antimicrobial therapy (e.g., for syphilis, TB, Lyme) if confirmed",
            "timing": "Delay",
            "reasons": [
              "Treat only if infectious cause identified",
              "Avoid unnecessary antibiotics without evidence"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute unilateral optic neuritis within treatment window",
              "Speeds visual recovery",
              "Standard first-line therapy for inflammatory optic neuritis"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CXR: Airspace disease with air bronchograms right upper lobe.)."
              ]
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: Airspace disease with air bronchograms right upper lobe.).\n\n- No indication this isn't an exacerbation of an old deficit/pseudorelapse."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Multiple sclerosis disease-modifying therapy",
            "timing": "Delay",
            "reasons": [
              "Start only if MRI/CSF support MS diagnosis or high-risk clinically isolated syndrome",
              "Choice depends on lesion burden and patient factors"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CXR: Airspace disease with air bronchograms right upper lobe.)."
              ]
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: Airspace disease with air bronchograms right upper lobe.)."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        }
      }
    }
  }
}